AbbVie and Tentarix Announce Collaboration to Develop Conditionally-Active, Multi-Specific Biologics…
AbbVie Inc. and Tentarix Biotherapeutics announced a multi-year collaboration focused on the discovery and development of conditionally-active, multi-specific biologic candidates in…
Read More...
Read More...